Does the expression of c-kit (CD117) in neuroendocrine tumors represent a target for therapy? (Q53588556)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17102120%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

title

Does the expression of c-kit (CD117) in neuroendocrine tumors represent a target for therapy? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17102120%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17102120%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Haifa Kathrin Al-Ali

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17102120%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

author name string

Oliver Gimm

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17102120%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Alexander O Vortmeyer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17102120%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Peter Lamesch

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17102120%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Rudolf Ott

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17102120%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Regine Kluge

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17102120%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Uta Bierbach

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17102120%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Andrea Tannapfel

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17102120%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

language of work or name

English

0 references

publication date

1 August 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17102120%20AND%20SRC:MED&resulttype=core&format=json

Annals of the New York Academy of Sciences

21 December 2019

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17102120%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

1073

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17102120%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

517-526

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17102120%20AND%20SRC:MED&resulttype=core&format=json

Cushing's syndrome due to ectopic corticotropin secretion: twenty years' experience at the National Institutes of Health

21 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1353.055

Pancreatic neuroendocrine tumor with ectopic adrenocorticotropin production upon second recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1353.055

Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1353.055

Effective long-term palliation of symptomatic, incurable metastatic medullary thyroid cancer by operative resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1353.055

Targeted therapy in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1353.055

KIT and platelet-derived growth factor receptor alpha tyrosine kinase gene mutations and KIT amplifications in human solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1353.055

Prevalence of KIT expression in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1353.055

The role of calretinin, inhibin, melan-A, BCL-2, and C-kit in differentiating adrenal cortical and medullary tumors: an immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1353.055

c-Kit is preferentially expressed in MYCN-amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI-571.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1353.055

Expression and mutational analysis of tyrosine kinase receptors c-kit, PDGFRalpha, and PDGFRbeta in ovarian cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1353.055

Imatinib mesylate lacks activity in small cell lung carcinoma expressing c-kit protein: a phase II clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1353.055

Occurrence of c-kit+ tumor cells in hepatitis B virus-associated hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1353.055

No GIST-type c-kit gain of function mutations in neuroblastic tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1353.055

KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1353.055

CD117 expression in glial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1353.055

Effects of the tyrosine kinase inhibitor imatinib on neuroendocrine tumor cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1353.055

Lack of clinical efficacy of imatinib in metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1353.055

A phase II trial of imatinib mesylate monotherapy in patients with metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1353.055

Malignant pheochromocytoma: current status and initiatives for future progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1353.055

Targeted therapy with imatinib: hits and misses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1353.055

21 January 2018

Identifiers

DOI

10.1196/ANNALS.1353.055

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17102120%20AND%20SRC:MED&resulttype=core&format=json

release_6xszfa4ozfayhpjdvn55sgfh3m

21 December 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6xszfa4ozfayhpjdvn55sgfh3m

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference